Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

ANALYSIS: Why emergency COVID-vaccine approvals pose a dilemma for scientists

Mon, 2020-11-23 13:19 — mike kraft

Why emergency COVID-vaccine approvals pose a dilemma for scientists Immunizations are speeding towards approval before clinical trials end, but scientists say this could complicate efforts to study long-term effects. David Cyranoski nature

After a flurry of positive results from clinical trials of COVID-19 vaccines, developers are now seeking ‘emergency use’ approvals, which could see these immunizations deployed in potentially tens of millions of people. But scientists are concerned that this kind of early deployment could compromise the ongoing clinical trials that seek to show conclusively how well the vaccines work.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about ANALYSIS: Why emergency COVID-vaccine approvals pose a dilemma for scientists
Log in or register to post comments

COVID-19 shots could reach first Americans by mid-December, top health official says

Mon, 2020-11-23 09:30 — mike kraft

COVID-19 shots could reach first Americans by mid-December, top health official says U.S. healthcare workers and others recommended for the nation's first COVID-19 inoculations could start getting shots within a day or two of regulatory consent next month, a top official of the government's vaccine development effort said on Sunday. Doina Chiacu U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID-19 shots could reach first Americans by mid-December, top health official says
Log in or register to post comments

AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective

Mon, 2020-11-23 09:19 — mike kraft

AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world's fight against the global pandemic a new weapon, cheaper to make, easier to distribute and faster to scale-up than rivals. Kate Holton, Josephine Mason, Kate Kelland U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective
Log in or register to post comments

Group of 20 leaders call for global coronavirus vaccine access as U.S. labs near approval

Sun, 2020-11-22 11:00 — mike kraft

Group of 20 leaders call for global coronavirus vaccine access as U.S. labs near approval The opening day of the virtual G-20 summit drew contrasts with Trump’s go-it-alone approach. Miriam Berger Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Group of 20 leaders call for global coronavirus vaccine access as U.S. labs near approval
Log in or register to post comments

Moderna CEO Cautions That COVID Vaccine Is 'Not a Silver Bullet' to End Pandemic

Fri, 2020-11-20 17:28 — mike kraft

Moderna CEO cautions that COVID vaccine is "not a silver bullet" to end pandemic "[The vaccine] is not a silver bullet. What we need is we need surveillance to be stronger, we need public health measures," Moderna CEO Stéphane Bancel said on Thursday. Newsweek

Stéphane Bancel, the CEO of the pharmaceutical company Moderna, warned on Thursday that a COVID-19 vaccine is not "a silver bullet," to end the pandemic, and advised people to continue wearing masks and follow public health guidelines.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna CEO Cautions That COVID Vaccine Is 'Not a Silver Bullet' to End Pandemic
Log in or register to post comments

Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US

Fri, 2020-11-20 17:20 — mike kraft

Pfizer, BioNTech seek emergency use of COVID-19 shots in US Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and... AP NEWS

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer, BioNTech formally seek emergency use of COVID-19 shots in US
Log in or register to post comments

AP roundup: U.S. official expects quick vaccine distribution, International developments

Fri, 2020-11-20 10:18 — mike kraft

The Latest: U.S. official expects quick vaccine distribution WASHINGTON — Gen. Gustave Perna of the Trump administration’s Operation Warp Speed vaccine program says about 40 million doses could be ready for distribution in the U.S. quickly if the Food and... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AP roundup: U.S. official expects quick vaccine distribution, International developments
Log in or register to post comments

The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.

Wed, 2020-11-18 13:48 — mike kraft

The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.

But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report